Consider the goal of therapy: palliative for metastatic disease; an early study suggested a decreased response rate to doxorubicin when dexrazoxane was used to prevent cardiac t i it toxicity Dexrazoxane may add to the hematologic toxicity of chemotherapy 
Considerations for Dexrazoxane
Dexrazoxane may be considered for patients with metastatic breast cancer who have received a cumulative dose of doxorubicin of > 300 mg/m 2 , and who may benefit from further drug This patient has received a cumulative doxorubicin dose This patient has received a cumulative doxorubicin dose sufficient to consider the use of dexrazoxane Answer B: The patient has reached the appropriate cumulative dose of doxorubicin to consider dexrazoxane. Which one of the following is the correct sequence for administering mesna and ifosfamide?
A. Mesna before ifosfamide and then at 4 and 8 hours after ifosfamide.
B. Ifosfamide before mesna and then at 4 and 8 hours after B. Ifosfamide before mesna and then at 4 and 8 hours after mesna.
C. Mesna and ifosfamide beginning and ending at the same time.
D. Mesna on day 1 and ifosfamide on days 2-5.
Handout Page 2-22; Answer Page 2-27
Considerations for Mesna
Mesna is a chemoprotectant that binds to acrolein to prevent the the binding of acrolein to the bladder and therefore causing sterile hemorrhagic cystitis
Mesna is always used with ifosfamide, and may be used with cyclophosphamide
Acrolein is a metabolite of both ifosfamide and cyclophosphamide that accumulates in the bladder. For chemoprotection, mesna must be available in the bladder when acrolein is present in the bladder. 
When bolus doses of mesna and ifosfamide are used, mesna should be given before ifosfamide, then 4 hours and 8 hours after ifosfamide
Answer A: Mesna before ifosfamide and then at 4 and 8 h f if f id hours after ifosfamide.
Patient Case # 10
A 40-year-old man is about to begin R-CHOP chemotherapy for large cell non Hodgkin lymphoma. The patient asks how long the treatment will take and whether he can be treated as an outpatient. Which one of the following is the best answer?
A. Administration of this regimen is expected to be complete in 1 hour, but because the regimen is highly emetogenic, it is usually given to patients while in the hospital. B Administration of this regimen may take as long as 6 hours because B. Administration of this regimen may take as long as 6 hours because the rituximab infusion rate is slowly increased, but the regimen is usually given to outpatients. C. Administration of this regimen may take as long as 6 hours because the vesicants doxorubicin and vincristine should be infused over several hours, but the regimen is usually given to outpatients. D. Administration of this regimen is expected to be complete in 1 hour, but because of the risk of tumor lysis syndrome, it is usually given to patients in the hospital.
Handout Page 2-24; Answer Page 2-27
Considerations for Administration of Chemotherapy
In the CHOP-R regimen, cyclophosphamide, doxorubicin and vincristine can all be given as bolus injections or short infusions. Prednisone is given orally.
Both doxorubicin and vincristine are vesicants, and it is , generally preferred to give vesicants as bolus injections. Vincristine is often given as a short infusion to avoid inadvertent intrathecal administration.
Rituximab and other chimeric antibodies are associated with infusion reactions. Thus the rate of administration of rituximab is usually titrated slowly 
Highly emetogenic chemotherapy is commonly given in the outpatient setting, with appropriate antiemetic prophylaxis.
Tumor lysis syndrome occurs subsequent to cell death in tumors that are rapidly growing and highly chemosensitive.
Large cell lymphoma is considered intermediate in terms of risk of developing TLS, and is commonly treated in the outpatient setting.
Page 2-24 (Answer pg 2-27-28)
In this patient, administration of CHOP-R may take as long as 6 hours because the rituximab infusion rate is slowly increased. But the CHOP-R regimen is usually given to outpatients.
Answer B: Administration of this regimen may take as long as 6 hours because the rituximab infusion rate is slowly increased, but the regimen is usually given to outpatients. A. Normal BMD of the spine. B.
Conflict of Interest Disclosures
Osteopenia of the spine. C.
Osteoporosis of the spine. D.
Osteoporosis is defined when a fracture has occurred. 
Lifestyle Modifications

Initiating Pharmacotherapy
Based on NOF, AACE, and NAMS recommendations: Hip or spine fracture T-score -2.5 or below at hip, spine, or femoral neck T-score between -1.0 and -2.5 with a 10-year probability of a hip fracture ≥ 3% OR a 10-year probability of a major osteoporosis-related fracture ≥ 20% based on the FRAX® tool (US-adapted WHO algorithm) Patient Case B C.A. is a 71-year-old white woman with a history of rheumatoid arthritis who smokes ½ pack/day. She takes calcium 500 mg /vitamin D 400 IU 3 times/day. She is 5′3″ and weighs 140 lbs. Her BMD T-score is −2.5 at the hip and −2.1 at the spine. Her FRAX score is 10-year major fracture risk of 22% and 10-year hip fracture risk of 9.6%.
Which one of the following is the best therapy for C.A.?
A. Teriparatide 20 mcg SQ daily. 
Pregnancy and Lactation
Patient Case C 
Which of the following statements is best to mention to D H 9. Which of the following statements is best to mention to D.H. regarding treatment of her herpes infection?
A. Treatment will decrease the risk of recurrent herpes infections. B. Treatment will shorten the duration of symptoms and infectivity of the initial infection. C. Treatment will decrease the severity of recurrent herpes infections. D. Treatment will prevent the virus from remaining latent in the dorsal root ganglia.
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Page 2-74, Answer Pages 2-86, 2-87
Patient Case F
D.H. returns to the clinic 10 months after her initial herpes infection. She is troubled by all of the recurrences she is having (seven to date). Which one of the following therapies is best to recommend?
A. Valacyclovir 500 mg orally 2 times/day to be used for 5 days whenever y g y y y she notices a recurrence beginning. B. Acyclovir 400 mg orally 3 times/day to be used for 10 days whenever she notices a recurrence beginning. C. Suppressive therapy with famciclovir 250 mg orally 3 times/day. D. Suppressive therapy with valacyclovir 500 mg/day orally. 
Which one of the following is the best empiric therapy?
A. Ampicillin/sulbactam 2 g IV every 6 hours for 14 days. B. Metronidazole 500 mg IV 3 times/day for 7 days. C. Cefotetan 2 g IV every 12 hours with doxycycline 100 mg orally every 12 hours for 14 days. D. Ceftriaxone 125 mg IM × 1 with doxycycline 100 mg IV 2 times/day for 7 days. Discontinued 24 hours after clinical improvement and switched to oral therapy for 14 days. Regimen A: cefotetan 2 g intravenously every 12 hours or cefoxitin 2 g intravenously every 6 hours PLUS doxycycline 100 mg intravenously or orally every 12 hours mg intravenously or orally every 12 hours Regimen B: clindamycin 900 mg intravenously every 8 hours PLUS gentamicin intravenously/intramuscularly 2-mg/kg loading dose; then 1.5 mg/kg every 8 hours (or once-daily therapy)
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Pelvic Inflammatory Disease
Alternative regimens:
Ampicillin-sulbactam 3 g intravenously every 6 hours plus doxycycline 100 mg intravenously or orally every 12 hours Ceftriaxone 250 mg intramuscularly once (other third-generation cephalosporins also acceptable) or cefoxitin 2 g intramuscularly plus probenecid 1 g orally once PLUS doxycycline 100 mg 2 times/day for 14 days with or without metronidazole 500 mg orally times/day for 14 days with or without metronidazole 500 mg orally 2 times/day for 14 days
Sexual partners of patients with PID within the past 60 days should be tested and treated. 11 Which one of the following is the best empiric therapy? 11. Which one of the following is the best empiric therapy?
A. Ampicillin/sulbactam 2 g intravenously every 6 hours for 14 days.
B. Metronidazole 500 mg intravenously 3 times/day for 7 days.
C. Cefotetan 2 g intravenously every 12 hours with doxycycline 100 mg orally every 12 hours for 14 days. D. Ceftriaxone 125 mg intramuscularly × 1 with doxycycline 100 mg intravenously 2 times/day for 7 days. 
Patient Case H
A 65-year-old man presents to his physician complaining of symptoms determined to be erectile dysfunction (ED). He has a history of hyperlipidemia, GERD, and glucose intolerance. His current medications include atorvastatin 20 mg PO daily, omeprazole 20 mg PO daily, and aspirin 81 mg PO daily as tolerated. He states that he heard of medications to help with his symptoms but does not want to have to plan out his intimate moments.
Which of the following drugs would work best for this patient?
A. Tadalafil 
Learning Objectives
Describe specific pharmacokinetic characteristics of commonly used therapeutic agents, including aminoglycosides, vancomycin, phenytoin, and digoxin, as well as pharmacokinetic alterations in patients ith l d h ti di with renal and hepatic disease. Basic PK Relationships D. is an efflux pump that decreases GI mucosa absorption.
(119)
Absorption P-glycoprotein:
CYP3A4 and P-glycoprotein in GI mucosa work together to decrease absorption efflux pump that pumps drug back into the GI lumen absorption drug interactions lumen -absorption drug interactions most CYP3A4 substrates are also P-glycoprotein substrates many CYP3A4 inhibitors/inducers also inhibit/induce P-glycoprotein example: verapamil or amiodarone or dronedarone and digoxin or dabigatran 96 Absorption P-glycoprotein:
A. is a plasma protein that binds basic drugs.
B. transfers drugs through the GI mucosa, increasing absorption. g p C. diminishes the effect of CYP3A4 in the GI mucosa.
D. is an efflux pump that decreases GI mucosa absorption. Table 3 Drug Transport Proteins SLC and ABC Superfamilies Table 4 97-98
Clearance
Renal transplant with CAP, also receiving cyclosporine. Which of the following would be the least likely to interact?
A conc. will ↓ significantly within the first few hours after HD. C. Wait a few hours to obtain the conc. since the conc. will ↑ significantly within the first few hours after HD. D. Wait until the next day so that all of the effects of hemodialysis have abated. conc. will ↓ significantly within the first few hours after HD. C. Wait a few hours to obtain the conc. since the conc. will ↑ significantly within the first few hours after HD. D. Wait until the next day so that all of the effects of hemodialysis have abated.
Data Collection and Analysis
A drug assay is touted as having high specificity but low sensitivity. This means:
A. The assay can't distinguish the drug from like products, but can detect extremely low concs.
B The assay can't distinguish the drug from like B. The assay can t distinguish the drug from like products, and can't detect extremely low concs.
C. The assay can distinguish the drug from like products, and can detect extremely low concs.
D. The assay can distinguish the drug from like products, but can't detect extremely low concs. 
PK in Hepatic Disease
SJ is a 55 year old male with fungemia PMH: hepatic dysfunction -ascites, no encephalopathy Started on caspofungin -decrease dose in ti t ith Child P h f 7 t 9 patients with Child-Pugh score of 7 to 9 Labs: AST = 85U/L, ALT = 56U/L, Alk phos = 190U/L, total bilirubin = 1.8mg/dl, albumin = 2.9g/dl, LDH = 270U/L, PT/INR = 14.6/1.7, GGT = 60U/L 110 (119)
What is his Child-Pugh score? 
Child-Pugh Classification for Liver Disease 
